Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,260 shares at $242.04 ($2.0M) on 2020-02-18, disclosed to the SEC on 2020-02-19.
Seasonal sale ($2.0M) by EVP, Chief Patient Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $241.50 | 3,262 | $788K | 39.3% |
| 2 | $242.04 | 720 | $174K | 8.7% |
| 3 | $242.04 | 720 | $174K | 8.7% |
| 4 | $242.85 | 1,260 | $306K | 15.3% |
| 5 | $244.08 | 540 | $132K | 6.6% |
| 6 | $244.08 | 540 |
| $132K |
| 6.6% |
| 7 | $245.15 | 720 | $177K | 8.8% |
| 8 | $245.82 | 249 | $61K | 3.1% |
| 9 | $245.82 | 249 | $61K | 3.1% |
| Total | $242.72 avg | 8,260 | $2.0M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |